Seer, Inc. (SEER)
Seer, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Seer, Inc. (SEER) is a Biotechnology company based in US with a market capitalization of $103.9M. Revenue grew 15.6% year-over-year and free cash flow was negative at -$46.2M. This page tracks SEER's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 134 employees · IPO Dec 4, 2020
Valuation
Valuation & price
$1.72as of May 17, 2026· -27.4% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.40
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$103.9M
Market cap
15.6%
Revenue growth (YoY)
11.8%
Gross margin
-$46.2M
Free cash flow (USD)
-$162.2M
Net debt
Net cash position
-7.9%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 2, 2026Filing
Acquisition Proposal
- 8-K eventMay 22, 2026Filing
Acquisition Proposal Rejected
- 8-K eventMay 13, 2026Filing
Earnings Release
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- 8-K eventMay 4, 2026Filing
CFO Appointment
- Annual reportApr 30, 2026Filing
10-K Filed
- 8-K eventApr 27, 2026Filing
Acquisition Proposal Rejected
- 8-K eventApr 13, 2026Filing
Acquisition Proposal Received
Questions
Frequently asked questions
What is Seer, Inc.'s market cap?
Seer, Inc. (SEER) has a market capitalization of $103.9M.
What is SEER's P/E ratio?
A meaningful P/E ratio is not available for SEER — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SEER's price-to-book (P/B) ratio?
SEER trades at 0.40 times book value per share.
Are insiders buying SEER stock?
SEC Form 4 filings show no open-market insider buys at Seer, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.